Paul Ruff

23.8k total citations · 4 hit papers
155 papers, 8.9k citations indexed

About

Paul Ruff is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Paul Ruff has authored 155 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Oncology, 28 papers in Pathology and Forensic Medicine and 28 papers in Epidemiology. Recurrent topics in Paul Ruff's work include Colorectal Cancer Treatments and Studies (35 papers), Viral-associated cancers and disorders (26 papers) and Global Cancer Incidence and Screening (22 papers). Paul Ruff is often cited by papers focused on Colorectal Cancer Treatments and Studies (35 papers), Viral-associated cancers and disorders (26 papers) and Global Cancer Incidence and Screening (22 papers). Paul Ruff collaborates with scholars based in South Africa, United States and United Kingdom. Paul Ruff's co-authors include Eric Van Cutsem, G. Bodoky, Michael Schlichting, Tamás Pintér, Anatoly Makhson, Gunnar Folprecht, Jae Kyung Roh, Philippe Rougier, J. Załuski and Johannes Nippgen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Paul Ruff

151 papers receiving 8.7k citations

Hit Papers

Cetuximab and Chemotherap... 2009 2026 2014 2020 2009 2010 2012 2014 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
    2009 2.9k citations Eric Van Cutsem, G. Bodoky et al. profile →
  2. Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
    2010 1.4k citations Jean‐Yves Douillard, Salvatore Siena et al. Journal of Clinical Oncology profile →
  3. Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
    2012 986 citations Eric Van Cutsem, Josep Tabernero et al. Journal of Clinical Oncology profile →
  4. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
    2014 339 citations Timothy Price, Marc Peeters et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul Ruff 6.4k 2.6k 1.8k 1.8k 1.4k 155 8.9k
Eduardo Díaz‐Rubio 8.7k 1.4× 3.5k 1.3× 2.0k 1.1× 1.9k 1.1× 2.0k 1.4× 351 12.0k
Miriam Koopman 5.7k 0.9× 1.9k 0.7× 1.4k 0.8× 2.0k 1.1× 1.1k 0.8× 222 8.0k
Bert H. O’Neil 5.7k 0.9× 2.0k 0.8× 1.1k 0.6× 1.3k 0.8× 2.5k 1.7× 255 9.1k
Edith P. Mitchell 8.8k 1.4× 3.6k 1.4× 1.5k 0.9× 1.4k 0.8× 2.4k 1.7× 205 12.1k
Tim Maughan 5.0k 0.8× 2.5k 0.9× 761 0.4× 1.4k 0.8× 1.1k 0.7× 243 7.7k
Christos S. Karapetis 8.2k 1.3× 3.8k 1.5× 1.3k 0.7× 2.8k 1.6× 2.0k 1.4× 314 11.2k
David Khayat 5.3k 0.8× 2.6k 1.0× 798 0.4× 1.2k 0.7× 2.4k 1.7× 108 8.4k
Brigette Ma 4.9k 0.8× 2.3k 0.9× 1.2k 0.7× 1.1k 0.6× 2.7k 1.9× 243 10.2k
Chiun Hsu 3.2k 0.5× 1.4k 0.5× 2.6k 1.4× 1.3k 0.7× 1.9k 1.3× 226 7.4k
Sandro Pignata 4.4k 0.7× 1.5k 0.6× 1.0k 0.6× 964 0.5× 2.4k 1.7× 434 10.6k

Countries citing papers authored by Paul Ruff

Since Specialization
Citations

This map shows the geographic impact of Paul Ruff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Ruff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Ruff more than expected).

Fields of papers citing papers by Paul Ruff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Ruff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Ruff. The network helps show where Paul Ruff may publish in the future.

Co-authorship network of co-authors of Paul Ruff

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Ruff. A scholar is included among the top collaborators of Paul Ruff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Ruff. Paul Ruff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruff, Paul, et al.. (2023). Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa. Cancer Medicine. 12(14). 15515–15529. 3 indexed citations
2.
Ayeni, Oluwatosin, Roslyn Thelingwani, Wenlong Carl Chen, et al.. (2023). Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co‐Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer. Clinical Pharmacology & Therapeutics. 114(1). 127–136. 6 indexed citations
3.
Mapanga, Witness, Oluwatosin Ayeni, Wenlong Carl Chen, et al.. (2023). The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approaches. SHILAP Revista de lepidopterología. 3(10). e0002432–e0002432. 1 indexed citations
4.
Mapanga, Witness, Shane A. Norris, Ashleigh Craig, et al.. (2023). Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort. PLoS ONE. 18(2). e0281916–e0281916. 5 indexed citations
5.
Dix‐Peek, Thérèse, Caroline Dickens, Tanya N. Augustine, et al.. (2023). Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Research and Treatment. 199(1). 1–12. 7 indexed citations
6.
Dix‐Peek, Thérèse, Caroline Dickens, Sarah Nietz, et al.. (2023). PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study. Breast Cancer Research and Treatment. 200(3). 337–346. 3 indexed citations
7.
Ayeni, Oluwatosin, Maureen Joffe, Witness Mapanga, et al.. (2023). Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study. Breast Cancer Research. 25(1). 7–7. 6 indexed citations
8.
Joffe, Maureen, Moosa Patel, Codruța Chiuzan, et al.. (2022). Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer Epidemiology Biomarkers & Prevention. 31(12). 2192–2198. 7 indexed citations
9.
10.
Ruff, Paul, et al.. (2020). Adjuvant trastuzumab in early HER2-positive breast cancer: Journeying towards the optimal duration of therapy in South Africa. South African Medical Journal. 110(4). 271–271. 3 indexed citations
11.
Peeters, Marc, Timothy Price, Michael Boedigheimer, et al.. (2018). Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study. Clinical Cancer Research. 25(4). 1216–1225. 32 indexed citations
12.
Cubasch, Herbert, Caroline Dickens, Maureen Joffe, et al.. (2018). Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11. Cancer Epidemiology. 52. 120–127. 33 indexed citations
13.
Cubasch, Herbert, Sarah Nietz, Caroline Dickens, et al.. (2018). Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV. The Breast. 43. 123–129. 15 indexed citations
14.
Ruff, Paul, Sana Al‐Sukhun, Charmaine Blanchard, & Lawrence N. Shulman. (2016). Access to Cancer Therapeutics in Low- and Middle-Income Countries. American Society of Clinical Oncology Educational Book. 35(36). 58–65. 50 indexed citations
15.
Oliner, Kelly S., Jean‐Yves Douillard, Salvatore Siena, et al.. (2013). Evaluation of KRAS, NRAS, and BRAF Mutations in Prime: Panitumumab with FOLFOX4 as First-Line Treatment in Metastatic Colorectal Cancer (MCRC). Annals of Oncology. 24. iv23–iv24. 2 indexed citations
16.
Ferry, David, Paul Ruff, Radek Lakomý, et al.. (2013). Time Course of Adverse Events in the Velour Trial. Annals of Oncology. 24. iv36–iv36. 1 indexed citations
17.
Cutsem, Eric Van, Josep Tabernero, Radek Lakomý, et al.. (2012). Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen. Journal of Clinical Oncology. 30(28). 3499–3506. 986 indexed citations breakdown →
18.
Douillard, Jean‐Yves, Salvatore Siena, James T. Cassidy, et al.. (2010). Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study. Journal of Clinical Oncology. 28(31). 4697–4705. 1351 indexed citations breakdown →
19.
Ruff, Paul, et al.. (2006). Intercondylar fossa of the femur: a novel region for DNA extraction. The South African Archaeological Bulletin. 61(183). 96–97. 2 indexed citations
20.
Lewis, Michael, et al.. (1985). Invasive Pulmonary Aspergillosis Complicating Influenza A Pneumonia in a Previously Healthy Patient. CHEST Journal. 87(5). 691–693. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Díaz‐Rubio Breakdown of academic impact, for papers by Miriam Koopman Breakdown of academic impact, for papers by Bert H. O’Neil Breakdown of academic impact, for papers by Edith P. Mitchell Breakdown of academic impact, for papers by Tim Maughan Breakdown of academic impact, for papers by Christos S. Karapetis Breakdown of academic impact, for papers by David Khayat Breakdown of academic impact, for papers by Brigette Ma Breakdown of academic impact, for papers by Chiun Hsu Breakdown of academic impact, for papers by Sandro Pignata
Rankless by CCL
2026